Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220830068> ?p ?o ?g. }
- W4220830068 endingPage "407" @default.
- W4220830068 startingPage "402" @default.
- W4220830068 abstract "Neurointerventionists lack guidelines for the use of antithrombotic therapies in their clinical practice; consequently, there is likely to be significant heterogeneity in antithrombotic use between centers. Through a nationwide survey, we aimed to obtain an exhaustive cross-sectional overview of antithrombotic use in neurointerventional procedures in France.In April 2021, French neurointerventional surgery centers were invited to participate in a nationwide 51-question survey disseminated through an active trainee-led research collaborative network (the JENI-RC).All 40 centers answered the survey. Fifty-one percent of centers reported using ticagrelor and 43% used clopidogrel as premedication before intracranial stenting. For flow diversion treatment, dual antiplatelet therapy was maintained for 3 or 6 months in 39% and 53% of centers, respectively, and aspirin was prescribed for 12 months or more than 12 months in 63% and 26% of centers, respectively. For unruptured aneurysms, the most common heparin bolus dose was 50 IU/kg (59%), and only 35% of centers monitored heparin activity for dose adjustment. Tirofiban was used in 64% of centers to treat thromboembolic complications. Fifteen percent of these comprehensive stroke centers reported using tenecteplase to treat acute ischemic strokes. Cangrelor appeared as an emergent drug in specific indications.This nationwide survey highlights the important heterogeneity in clinical practices across centers. There is a pressing need for trials and guidelines to further evaluate and harmonize antithrombotic regimens in the neurointerventional field." @default.
- W4220830068 created "2022-04-03" @default.
- W4220830068 creator A5001306825 @default.
- W4220830068 creator A5001653923 @default.
- W4220830068 creator A5004397899 @default.
- W4220830068 creator A5005301407 @default.
- W4220830068 creator A5008196792 @default.
- W4220830068 creator A5009382035 @default.
- W4220830068 creator A5018643132 @default.
- W4220830068 creator A5019529967 @default.
- W4220830068 creator A5019580884 @default.
- W4220830068 creator A5021635866 @default.
- W4220830068 creator A5023396427 @default.
- W4220830068 creator A5028577166 @default.
- W4220830068 creator A5029464386 @default.
- W4220830068 creator A5030929698 @default.
- W4220830068 creator A5031359980 @default.
- W4220830068 creator A5032634716 @default.
- W4220830068 creator A5037073788 @default.
- W4220830068 creator A5037193375 @default.
- W4220830068 creator A5038761624 @default.
- W4220830068 creator A5040007729 @default.
- W4220830068 creator A5047184481 @default.
- W4220830068 creator A5048122758 @default.
- W4220830068 creator A5048427416 @default.
- W4220830068 creator A5048624747 @default.
- W4220830068 creator A5048720974 @default.
- W4220830068 creator A5051140972 @default.
- W4220830068 creator A5051812739 @default.
- W4220830068 creator A5054897620 @default.
- W4220830068 creator A5055259780 @default.
- W4220830068 creator A5055910169 @default.
- W4220830068 creator A5057937012 @default.
- W4220830068 creator A5060055969 @default.
- W4220830068 creator A5062053087 @default.
- W4220830068 creator A5065240826 @default.
- W4220830068 creator A5067045047 @default.
- W4220830068 creator A5068584549 @default.
- W4220830068 creator A5070194067 @default.
- W4220830068 creator A5072737556 @default.
- W4220830068 creator A5073234388 @default.
- W4220830068 creator A5076968069 @default.
- W4220830068 creator A5077467008 @default.
- W4220830068 creator A5079265798 @default.
- W4220830068 creator A5080213550 @default.
- W4220830068 creator A5081479292 @default.
- W4220830068 creator A5083231514 @default.
- W4220830068 creator A5085131541 @default.
- W4220830068 creator A5089146159 @default.
- W4220830068 creator A5089597237 @default.
- W4220830068 date "2022-03-28" @default.
- W4220830068 modified "2023-10-06" @default.
- W4220830068 title "Antithrombotic therapies for neurointerventional surgery: a 2021 French comprehensive national survey" @default.
- W4220830068 cites W1932887181 @default.
- W4220830068 cites W1958005423 @default.
- W4220830068 cites W1967319866 @default.
- W4220830068 cites W1985059672 @default.
- W4220830068 cites W1989340665 @default.
- W4220830068 cites W2023948086 @default.
- W4220830068 cites W2085260510 @default.
- W4220830068 cites W2090948001 @default.
- W4220830068 cites W2092022893 @default.
- W4220830068 cites W2124360594 @default.
- W4220830068 cites W2156973611 @default.
- W4220830068 cites W2329161954 @default.
- W4220830068 cites W2331820709 @default.
- W4220830068 cites W2530350735 @default.
- W4220830068 cites W2610167075 @default.
- W4220830068 cites W2610254229 @default.
- W4220830068 cites W2767430583 @default.
- W4220830068 cites W2767847369 @default.
- W4220830068 cites W2781254208 @default.
- W4220830068 cites W2782953040 @default.
- W4220830068 cites W2791225080 @default.
- W4220830068 cites W2902635828 @default.
- W4220830068 cites W2905063800 @default.
- W4220830068 cites W2905095813 @default.
- W4220830068 cites W2913105430 @default.
- W4220830068 cites W2938082104 @default.
- W4220830068 cites W2954006935 @default.
- W4220830068 cites W2963016818 @default.
- W4220830068 cites W2974347520 @default.
- W4220830068 cites W2998215100 @default.
- W4220830068 cites W3025672389 @default.
- W4220830068 cites W3033795260 @default.
- W4220830068 cites W3043375525 @default.
- W4220830068 cites W3087285445 @default.
- W4220830068 cites W3097487224 @default.
- W4220830068 cites W3107450239 @default.
- W4220830068 cites W3108900488 @default.
- W4220830068 cites W3117228373 @default.
- W4220830068 cites W3134863792 @default.
- W4220830068 cites W3140873972 @default.
- W4220830068 cites W3156805168 @default.
- W4220830068 cites W3168572807 @default.
- W4220830068 cites W3180150609 @default.
- W4220830068 cites W3205262398 @default.
- W4220830068 cites W4214651108 @default.